Investigative Site

Everett, Washington 98208

0 studies enrolling now · 2 studies all time

What they study most

Irritable Bowel Syndrome With Diarrhea (IBS-D), Overactive Bladder (OAB)

Studies at this site

• Efficacy, Safety and Tolerability of DNK333 (25 mg Bid) in Women With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) — Completed
• Patient's Perception of Treatment Outcome With Darifenacin by Patients With Overactive Bladder — Completed